Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avraham Kadar


Dr. Avraham Kadar is the Founder and serves as Investor at He is the Founder and serves as Executive Chairman at Avraham Kadar. He served as Chief Executive Officer at BrainPOP. He is a graduate of Sackler Medical School in Tel Aviv, Israel. He trained in Pediatrics in Israel and at the Albert Einstein College of Medicine and Montefiore Hospital in New York. He was a Fellow at the Laboratory of Clinical Investigation at the National Institutes of Health in Bethesda, MD. Dr. Kadar is board certified in Pediatrics and Diagnostic Laboratory Immunology. He also holds the position of Assistant Clinical Professor, Division of Allergy and Immunology, at the Albert Einstein College of Medicine.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • 71 West 23rd Street
  • 17th floor
  • New York, NY 10010
  • United States

Avraham Kadar Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Tailor-ED 31-Oct-2019 Seed Round 00.00 Educational Software Generating Revenue 0000000 00000 00
0000000000 08-Nov-2011 00000 (00000 00.000 Information Services (B2C) Out of Business 0000000 00000 00
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avraham Kadar’s full profile, request a free trial.

Avraham Kadar Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 01-Apr-2015 000 00 00000000 Completed
To view this investor’s complete exits history, request access »

Avraham Kadar Team (1)

Name Title Deals Funds Boards Office Contact
Avraham Kadar MD Angel Investor 0 0 New York, NY

Avraham Kadar Co-Investors (5)

Name With Exits Lead Partner
Benson Oak Ventures 1 0
Elevate Education 0 0
Emerge Education 0 0
Fresh.Fund 0 0
Y Combinator 0 0
To view this investor’s complete co-investor history, request access »